Major research on disease:
CLL patients are encouraged to explore clinical trials. Clinical trials test new drugs and treatments, many of which are being supported by LLS research programs, before they are approved by the FDA as standard treatment. Present ongoing present trend of clinical researched are follows Kinase Inhibitor Therapy, Monoclonal Antibody, Immunomodulatory Drug and Improvements in Stem Cell Transplantation.
Estimated total Ph+ CMLpatients in Belgium is about 8,373(2015) may be increased to 10,782(2040) to the total of worldwide presentation 1,363,249.